LANSOPRAZOLE

lansoprazole 30 mg enteric capsule, 28

LANSOPRAZOLE (2240X)

lansoprazole 30 mg enteric capsule, 28
2240X
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  8775

Indication: Peptic ulcer
Treatment phase: Initial treatment

Restriction  8774

Indication: Gastro-oesophageal reflux disease
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 28 # of repeats: 1 DPMQ: $18.09 Max safety net: $19.57 General Patient Charge: $22.36
Available brands
APO-Lansoprazole
Lanzopran
Zopral